Willie Earley

3.3k total citations
82 papers, 2.0k citations indexed

About

Willie Earley is a scholar working on Psychiatry and Mental health, Pharmacology and Experimental and Cognitive Psychology. According to data from OpenAlex, Willie Earley has authored 82 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Psychiatry and Mental health, 32 papers in Pharmacology and 12 papers in Experimental and Cognitive Psychology. Recurrent topics in Willie Earley's work include Schizophrenia research and treatment (44 papers), Bipolar Disorder and Treatment (43 papers) and Treatment of Major Depression (32 papers). Willie Earley is often cited by papers focused on Schizophrenia research and treatment (44 papers), Bipolar Disorder and Treatment (43 papers) and Treatment of Major Depression (32 papers). Willie Earley collaborates with scholars based in United States, Hungary and Canada. Willie Earley's co-authors include I. Laszlovszky, György Németh, Suresh Durgam, Lakshmi N. Yatham, Kaifeng Lu, Eduard Vieta, B. Szatmári, Mehul Patel, Johan Szamosi and Sanjeev Pathak and has published in prestigious journals such as American Journal of Psychiatry, Neuropsychopharmacology and Journal of Affective Disorders.

In The Last Decade

Willie Earley

82 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Willie Earley United States 26 1.6k 690 276 245 238 82 2.0k
György Németh Hungary 25 1.6k 1.0× 460 0.7× 449 1.6× 206 0.8× 280 1.2× 86 2.1k
Suresh Durgam United States 27 1.9k 1.2× 605 0.9× 513 1.9× 270 1.1× 391 1.6× 94 2.4k
Mary Hobart United States 20 1.2k 0.7× 785 1.1× 123 0.4× 185 0.8× 215 0.9× 49 1.6k
Pierre V. Trân United States 17 1.5k 0.9× 616 0.9× 174 0.6× 175 0.7× 297 1.2× 28 1.9k
Jayendra K. Patel United States 16 2.0k 1.2× 433 0.6× 192 0.7× 148 0.6× 515 2.2× 22 2.4k
Juan Undurraga Chile 18 1.2k 0.7× 413 0.6× 91 0.3× 159 0.6× 295 1.2× 58 1.7k
S.H. Hamilton United States 18 2.4k 1.5× 725 1.1× 210 0.8× 201 0.8× 483 2.0× 41 3.0k
Hans Eriksson United States 25 1.2k 0.8× 1.1k 1.5× 196 0.7× 562 2.3× 360 1.5× 71 2.2k
Ibrahim Turkoz United States 22 1.3k 0.9× 566 0.8× 93 0.3× 184 0.8× 411 1.7× 98 1.8k
Caroline Corves Germany 6 1.7k 1.1× 311 0.5× 221 0.8× 138 0.6× 360 1.5× 11 2.2k

Countries citing papers authored by Willie Earley

Since Specialization
Citations

This map shows the geographic impact of Willie Earley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Willie Earley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Willie Earley more than expected).

Fields of papers citing papers by Willie Earley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Willie Earley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Willie Earley. The network helps show where Willie Earley may publish in the future.

Co-authorship network of co-authors of Willie Earley

This figure shows the co-authorship network connecting the top 25 collaborators of Willie Earley. A scholar is included among the top collaborators of Willie Earley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Willie Earley. Willie Earley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Durgam, Suresh, Willie Earley, Changzheng Chen, et al.. (2025). Lumateperone for the Treatment of Major Depressive Disorder With Mixed Features or Bipolar Depression With Mixed Features. Journal of Clinical Psychopharmacology. 45(2). 67–75. 5 indexed citations
2.
Durgam, Suresh, Willie Earley, Yifan Mo, et al.. (2025). Adjunctive Lumateperone in Patients With Major Depressive Disorder: Results From a Randomized, Double-Blind, Phase 3 Trial. American Journal of Psychiatry. 182(12). 1072–1082. 1 indexed citations
3.
Riccobene, Todd, Robert Riesenberg, Paul Yeung, Willie Earley, & Arlene Hankinson. (2022). Pharmacokinetics, Safety, and Tolerability of Cariprazine in Pediatric Patients with Bipolar I Disorder or Schizophrenia. Journal of Child and Adolescent Psychopharmacology. 32(8). 434–443. 5 indexed citations
4.
5.
McIntyre, Roger S., Prakash S. Masand, Willie Earley, & Mehul Patel. (2019). Cariprazine for the treatment of bipolar mania with mixed features: A post hoc pooled analysis of 3 trials. Journal of Affective Disorders. 257. 600–606. 21 indexed citations
6.
Fava, Maurizio, Suresh Durgam, Willie Earley, et al.. (2018). Efficacy of adjunctive low-dose cariprazine in major depressive disorder. International Clinical Psychopharmacology. 33(6). 312–321. 43 indexed citations
7.
Earley, Willie, Hua Guo, David G. Daniel, et al.. (2018). Efficacy of cariprazine on negative symptoms in patients with acute schizophrenia: A post hoc analysis of pooled data. Schizophrenia Research. 204. 282–288. 53 indexed citations
8.
Findling, Robert L., Willie Earley, Trisha Suppes, et al.. (2018). Post hoc analyses of asenapine treatment in pediatric patients with bipolar I disorder: efficacy related to mixed or manic episode, stage of illness, and body weight. Neuropsychiatric Disease and Treatment. Volume 14. 1941–1952. 3 indexed citations
9.
Vieta, Eduard, Willie Earley, Suresh Durgam, et al.. (2018). Long-term safety and tolerability of cariprazine as adjunctive therapy in major depressive disorder. International Clinical Psychopharmacology. 34(2). 76–83. 22 indexed citations
10.
Earley, Willie, Suresh Durgam, Kaifeng Lu, et al.. (2017). Tolerability of cariprazine in the treatment of acute bipolar I mania: A pooled post hoc analysis of 3 phase II/III studies. Journal of Affective Disorders. 215. 205–212. 25 indexed citations
11.
Earley, Willie, Suresh Durgam, Kaifeng Lu, et al.. (2017). Safety and tolerability of cariprazine in patients with acute exacerbation of schizophrenia. International Clinical Psychopharmacology. 32(6). 319–328. 50 indexed citations
12.
Durgam, Suresh, Willie Earley, Hua Guo, et al.. (2016). Efficacy and Safety of Adjunctive Cariprazine in Inadequate Responders to Antidepressants. The Journal of Clinical Psychiatry. 77(3). 371–378. 92 indexed citations
13.
Weisler, Richard H., Stuart Montgomery, Willie Earley, Johan Szamosi, & Hans Eriksson. (2014). Extended Release Quetiapine Fumarate in Patients With Major Depressive Disorder. The Journal of Clinical Psychiatry. 75(5). 520–527. 7 indexed citations
14.
Findling, Robert L., Sanjeev Pathak, Willie Earley, Sherry Liu, & Melissa P. DelBello. (2014). Efficacy and Safety of Extended-Release Quetiapine Fumarate in Youth with Bipolar Depression: An 8 Week, Double-Blind, Placebo-Controlled Trial. Journal of Child and Adolescent Psychopharmacology. 24(6). 325–335. 54 indexed citations
15.
16.
Findling, Robert L., Sanjeev Pathak, Willie Earley, Sherry Liu, & Melissa P. DelBello. (2013). Safety, Tolerability, and Efficacy of Quetiapine in Youth with Schizophrenia or Bipolar I Disorder: A 26-Week, Open-Label, Continuation Study. Journal of Child and Adolescent Psychopharmacology. 23(7). 490–501. 19 indexed citations
17.
Trivedi, Madhukar H., Borwin Bandelow, Koen Demyttenaere, et al.. (2013). Evaluation of the effects of extended release quetiapine fumarate monotherapy on sleep disturbance in patients with major depressive disorder: a pooled analysis of four randomized acute studies. The International Journal of Neuropsychopharmacology. 16(8). 1733–1744. 22 indexed citations
18.
Young, Allan H., Joseph R. Calabrese, U. Gustafsson, et al.. (2013). Quetiapine monotherapy in bipolar II depression: combined data from four large, randomized studies. International Journal of Bipolar Disorders. 1(1). 10–10. 22 indexed citations
19.
Constant, E., et al.. (2008). Once-daily extended release quetiapine fumarate (quetiapine XR) as adjunct to) antidepressant therapy fit patients with major depressive disorder. The International Journal of Neuropsychopharmacology. 11. 184–184. 4 indexed citations
20.
Winter, Helen, et al.. (2008). Steady-State Pharmacokinetic, Safety, and Tolerability Profiles of Quetiapine, Norquetiapine, and Other Quetiapine Metabolites in Pediatric and Adult Patients with Psychotic Disorders. Journal of Child and Adolescent Psychopharmacology. 18(1). 81–98. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by György Németh Breakdown of academic impact, for papers by Suresh Durgam Breakdown of academic impact, for papers by Mary Hobart Breakdown of academic impact, for papers by Pierre V. Trân Breakdown of academic impact, for papers by Jayendra K. Patel Breakdown of academic impact, for papers by Juan Undurraga Breakdown of academic impact, for papers by S.H. Hamilton Breakdown of academic impact, for papers by Hans Eriksson Breakdown of academic impact, for papers by Ibrahim Turkoz Breakdown of academic impact, for papers by Caroline Corves
Rankless by CCL
2026